Basic information

Biomarker: miR-151a-5

Histology type: endometrial carcinoma

Cohort characteristics

Country: China

Region: Nanjing

Followed up time :

Subgroup 1 name : external validation

Subgroup 1 number: 27

Subgroup 2 name: controls

Subgroup 2 number: 23

Cohort statistics: cutoff<50;cutoff>50

Total number Group I Group I number Group II Group II number Group III Group III number Group IV Group IV number
172 endometrial cancer 93 healthy 79

Sample information

Description: A signature consisting of 3 plasma miRNAs was identified and showed potential for the non-invasive diagnosis of EC.

Sample type : plasma

Sample method: qRT-PCR

Expression pattern : Ct-value < 37, 1.5-fold altered expression in EC patients compared with healthy controls

Expression elevation: The expression of miRNAs in plasma or exosomes was calculated using the 2−∆∆Ct method (cel-miR-39 as exogenous reference miRNA for plasma samples; RNU6B (U6) [U6] for tissue sample normalization; ∆Ct = Ct miRNA − Ct normalizer; Ct: the threshold cycle)

Disease information

Cohort age: 22;28

Subgroup 1 age: 9;18

Subgroup 2 age: 13;10

Related information

HGNC miRNA approved symbol: MIR151A

HGNC miRNA approved name: microRNA 151a

HGNC miRNA locus type: RNA, micro

HGNC miRNA symbol status: Approved

HGNC miRNA ID: HGNC:31762

HGNC miRNA link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:31762

Stem loop sequence symbol: hsa-mir-151a

Stem loop sequence accession: MI0000809

Stem loop sequence gene family: MIPF0000057

Stem loop sequence annotation confidence: not enough data

Mature sequence symbol: hsa-miR-151a-5p$hsa-miR-151a-3p

Mature sequence accession: MIMAT0004697$MIMAT0000757

Previous IDs: hsa-miR-151-5p$hsa-miR-151;hsa-miR-151-3p

Evidence: experimental; cloned [PMID:17604727,PMID:17616659],experimental; cloned [PMID:15978578,PMID:17604727,PMID:17616659], Northern [PMID:15978578]

miRBase link: https://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000809

Visulization